|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
11,557,466 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-08-01 |
4 |
AS |
$21.60 |
$108,000 |
D/D |
(5,000) |
26,579 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-08-01 |
4 |
OE |
$4.00 |
$20,000 |
D/D |
5,000 |
31,579 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-08-01 |
4 |
AS |
$21.54 |
$258,900 |
D/D |
(12,000) |
640,828 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-08-01 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
647,828 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-07-17 |
4 |
AS |
$21.10 |
$253,224 |
D/D |
(12,000) |
640,828 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-07-17 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,828 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
22,508 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2006-07-03 |
4 |
D |
$24.26 |
$50,364 |
D/D |
(2,076) |
14,508 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2006-07-03 |
4 |
OE |
$20.45 |
$46,874 |
D/D |
2,292 |
16,584 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
48,336 |
640,828 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-07-03 |
4 |
AS |
$23.84 |
$286,044 |
D/D |
(12,000) |
592,492 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-07-03 |
4 |
OE |
$5.33 |
$99,279 |
D/D |
13,727 |
594,492 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-07-03 |
4 |
D |
$24.26 |
$37,943 |
D/D |
(1,564) |
592,492 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
10,738 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2006-07-03 |
4 |
D |
$24.26 |
$67,152 |
D/D |
(2,768) |
2,738 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2006-07-03 |
4 |
OE |
$25.01 |
$76,431 |
D/D |
3,056 |
5,506 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
23,879 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-07-03 |
4 |
D |
$24.26 |
$30,010 |
D/D |
(1,237) |
17,379 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-07-03 |
4 |
OE |
$20.45 |
$27,916 |
D/D |
1,365 |
18,616 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
12,948 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2006-07-03 |
4 |
D |
$24.26 |
$49,709 |
D/D |
(2,049) |
6,448 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2006-07-03 |
4 |
OE |
$20.45 |
$46,260 |
D/D |
2,262 |
8,497 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-07-03 |
4 |
D |
$24.26 |
$48,690 |
D/D |
(2,007) |
26,579 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-07-03 |
4 |
OE |
$4.00 |
$65,319 |
D/D |
7,216 |
28,586 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
26,322 |
|
- |
|
801 Records found
|
|
Page 22 of 33 |
|
|